Healthcare
LifeMD, Inc.(LFMDP)
Live Price
Offline$23.50
-1.38% today
1Y Change
-3.09%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $230.00M
- Revenue Growth
- -8.7%
- EPS Growth
- +56.6%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
LifeMD, Inc. (LFMDP) is a Healthcare stock with a market cap of $230.00M and listed on NASDAQ. The stock last traded around $23.50 and down 3.1% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -8.7%, EPS growth of +56.6%, a dividend yield of 0.0%. What stands out right now is revenue -8.7%, EPS +56.6%, free cash flow +7.2% with operating margin -0.6% and ROIC -4.9%. Valuation is more restrained than many high-expectation growth names at price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines LFMDP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-8.7% vs +7.6% peer median
Operating Margin
Below sector median
-0.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 8, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -8.7% and EPS is at +56.6%, with operating margin around -0.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.7% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 8, 2026 | โ | +0.4% | +1.2% | +0.6% |
2026 Mar 9, 2026 | +724.0% | +2.5% | +2.7% | +1.6% |
2025 Nov 17, 2025 | -312.3% | -1.1% | -1.7% | -9.0% |
Benchmark Edge
LFMDP vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
LFMDP
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
LFMDP Max Drawdown
-18.52%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for LFMDP and SPY.
Company Overview
LifeMD, Inc.
NASDAQ Global Market
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
- Leadership
- Justin Schreiber
- IPO Date
- Oct 5, 2021
- Employees
- 304
- Street Address
- 236 Fifth Avenue
- Mailing
- New York City, NY, 10001
- Region
- New York City, NY, US
- Reporting Currency
- USD
- Investor Line
- 866 351 5907
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 26.0
- Price/Sales
- 1.0
- Price/Book
- 9.8
Growth
- Revenue
- -8.7%
- EPS
- +56.6%
- Free Cash Flow
- +7.2%
Profitability
- Gross Margin
- 86.4%
- Operating Margin
- -0.6%
- Net Margin
- -2.6%
- ROE
- -117.7%
- ROIC
- -4.9%
Balance Sheet
- Debt/Equity
- 0.27
- Current Ratio
- 1.25
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.